potential side effects of glp 1 Adverse GLP-1 Receptor Agonists How to Avoid the Side

In some cases, medications to manage nausea or promote motility may be considered, but these should always be discussed with a healthcare provider

The FDA has a special program called "expanded access" (sometimes called compassionate use) for people who are seriously ill and have run out of options

Monlunabant: A treatment for obesity Developed by Novo Nordisk, Monlunabant is not a GLP-1 receptor agonist at all, but a treatment for obesity

39 , 24332439.e1 (2024)

Her weight remained stable until last year, when pounds began creeping back, despite adhering to a strict diet and lots of exercise

If side effects are a concern, our Zepbound side effects guide covers what to expect at every dose level